Mode
Text Size
Log in / Sign up

Micro- and nanoplastics may disrupt bone remodeling by impairing osteogenesis and promoting macrophage-associated osteoclastogenesisMicroplastics may cause bone health problems by disrupting cell balance

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that MNPs may disrupt bone remodeling via inflammatory pathways, though human data remains limited.

This narrative review synthesizes evidence regarding the impact of micro- and nanoplastics (MNPs) on bone remodeling processes. The scope includes evaluating how these particles influence osteogenesis, macrophage-associated osteoclastogenesis, oxidative stress, and nuclear factor-kappaB (NF-kB) signaling. The authors also examine potential roles for NLRP3 inflammasome activation, gut microbiota dysbiosis, and endocrine disruption in the context of bone health.

The review suggests that MNPs may disturb osteoimmunological homeostasis by impairing osteogenesis while promoting macrophage-associated osteoclastogenesis, which favors a bone remodeling imbalance. These findings are based on experimental evidence and mechanisms involving inflammatory pathways and environmental stressors.

A primary limitation noted is the lack of extensive human detection data for these particles in clinical contexts. While the review identifies potential risks to bone health, the link between MNPs and bone remodeling disruption remains largely supported by experimental models rather than large-scale human trials.

Clinical relevance is currently focused on risk assessment. The authors suggest that future research should incorporate osteoimmunological endpoints when assessing MNP risks for vulnerable populations, specifically pediatric and geriatric patients. Current evidence is insufficient to establish definitive clinical outcomes in humans.

Imagine your bones as a living structure that constantly repairs itself. This process relies on a delicate balance between cells that build bone and those that break it down. New research suggests that micro- and nanoplastics (tiny plastic particles) might be throwing this balance off, making it harder for the body to maintain strong bones.

The review looked at how these small plastics interact with our immune systems and bone cells. The findings suggest that these particles can cause stress and trigger inflammation. Specifically, they may hinder the creation of new bone while encouraging the breakdown of existing bone. This happens through several pathways, including the activation of certain inflammatory proteins.

While the evidence comes from experimental studies rather than large human trials, it highlights a growing concern for children and older adults. Because we currently have limited data on how much plastic people actually have in their bodies, these results are early. However, they show why we need to look closer at how environmental plastics affect our skeletal health.

What this means for you:
Tiny plastic particles may disrupt the balance of bone-building cells and trigger harmful inflammation.

Common questions

What are micro- and nanoplastics?

These are very small pieces of plastic. Microplastics are tiny particles, while nanoplastics are even smaller. Because they are so small, they can enter different parts of the body and interact with our cells and immune system.

How do these plastics affect bone health?

They may cause a balance issue in bone remodeling. This means they could make it harder for your body to build new bone while making it easier for the body to break down old bone, which can lead to an imbalance.

Is there enough evidence to know if this happens in humans?

The current evidence is based on experimental studies and there is limited data on how much plastic is actually found in humans. More research is needed to fully understand the risks for people.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Ingested environmental micro- and nanoplastics (MNPs) may represent an emerging systemic health concern. Although toxicological research has mainly focused on the gastrointestinal tract, increasing evidence suggests that the highly vascularized bone marrow may also be a relevant site for MNP accumulation. This narrative review proposes a “gut-immune-bone” axis linking intestinal barrier disruption, systemic translocation, and potential deposition within the bone marrow niche. Current experimental evidence, together with limited human detection data, suggests that MNPs may disturb osteoimmunological homeostasis by impairing osteogenesis and promoting macrophage-associated osteoclastogenesis, thereby favoring bone remodeling imbalance. We summarize potential mechanisms, including oxidative stress, nuclear factor-κB (NF-κB) signaling, NOD-like receptor protein 3 (NLRP3) inflammasome activation, gut microbiota dysbiosis, endocrine disruption, and MNP-heavy metal co-exposure. We also discuss susceptible pediatric and geriatric populations and highlight the need to incorporate osteoimmunological endpoints into future MNP risk assessment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.